Profil
Jason D.
Fontenot served as the Chief Scientific Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2021 to 2024.
Prior to that, he was the Chief Scientific Officer at Immusoft Corp.
from 2018 to 2019.
Before joining Immusoft Corp., he worked as the Head-Exploratory Research at Juno Therapeutics, Inc. from 2016 to 2018.
Mr. Fontenot holds a doctorate degree from the University of Washington.
Ehemalige bekannte Positionen von Jason Fontenot
| Unternehmen | Position | Ende |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2024 |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2019 |
| JUNO THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Ausbildung von Jason Fontenot
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Health Services |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
















